4 results
DEF 14A
CRGX
CARGO Therapeutics, Inc. Common Stock
24 Apr 24
Definitive proxy
4:27pm
The table below sets forth the number of shares of Series A-1 Preferred Stock, Series Seed Preferred Stock and Series A-2 Preferred Stock purchased by our executive officers, directors, holders of more than 5% of our capital stock and their affiliated entities or immediate family members. Each share of Series Seed Preferred Stock, Series A-1 Preferred Stock and Series A-2 Preferred Stock in the table below converted into one share of our common stock immediately prior to the completion of our IPO in November 2023.
Name | Series Seed convertible preferred stock (#) | Series A-1 convertible preferred stock (#) | Series A-2 convertible preferred stock (#) | Aggregate purchase price ($) | ||||||||||||
Samsara BioCapital, L.P.(1) | 663,300 | 884,400 | 1,833,623 | $ | 39,187,097.00 | |||||||||||
Red Tree Venture Fund, L.P.(2) | 73,700 | 626,449 | 1,105,158 | $ | 20,429,032.00 | |||||||||||
Perceptive Xontogeny Venture Fund II, LP(3) | — | 2,579,502 | — | $ | 35,000,000.00 | |||||||||||
Third Rock Ventures V, L.P.(4) | — | 2,211,002 | — | $ | 30,000,000.00 | |||||||||||
Nextech VII Oncology SCSP(5) | — | 1,842,502 | — | $ | 25,000,000.00 | |||||||||||
Janus Henderson Biotech Innovation Master Fund Limited(6) | — | 1,474,001 | — | $ | 20,000,000.00 | |||||||||||
Entities affiliated with RTW Funds(7) | — | 1,842,499 | — | $ | 25,000,000.00 |
DEF 14A
CRGX
CARGO Therapeutics, Inc. Common Stock
24 Apr 24
Definitive proxy
4:27pm
Percentage ownership of our common stock in the table is based on 39,368,647 shares of our common stock issued and outstanding on April 5, 2024. The table below does not reflect ownership of outstanding shares of our non-voting common stock. This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13D and Schedules 13G, if any, filed with the SEC. Unless otherwise indicated, the address of each of the individuals and entities named below is c/o CARGO Therapeutics, Inc., 835 Industrial Road, San Carlos, California 94070.
Beneficial Ownership | ||||||||||||||||
Name of Beneficial Owner | Number of Outstanding Shares Beneficially Owned | Number of Shares Exercisable Within 60 Days | Number of Shares Beneficially Owned | Percentage of Beneficial Ownership | ||||||||||||
5% and Greater Stockholders: | ||||||||||||||||
FMR LLC(1) | 6,180,771 | — | 6,180,771 | 15.70 | % | |||||||||||
Funds affiliated with Third Rock Ventures(2) | 3,544,335 | 3,544,335 | 9.00 | % | ||||||||||||
Funds affiliated with Perceptive Advisors(3) | 3,436,600 | — | 3,436,600 | 8.73 | % | |||||||||||
Janus Henderson Biotech Innovation Master Fund Limited(4) | 2,702,731 | — | 2,702,731 | 6.87 | % | |||||||||||
T. Rowe Price Associates, Inc.(5) | 2,238,507 | — | 2,238,507 | 5.69 | % | |||||||||||
Named Executive Officers and Directors: | ||||||||||||||||
Gina Chapman(6) | 103,905 | 223,052 | 326,957 | * | ||||||||||||
Anup Radhakrishnan(7) | 6,446 | 47,253 | 53,699 | * | ||||||||||||
Ginna Laport, M.D. (8) | — | 10,416 | 10,416 | * | ||||||||||||
Abraham Bassan(9) | — | 4,166 | 4,166 | * | ||||||||||||
Reid Huber, Ph.D. (10) | — | 4,166 | 4,166 | * | ||||||||||||
David C. Lubner(11) | — | 9,923 | 9,923 | * | ||||||||||||
John Orwin(12) | — | 49,693 | 49,693 | * | ||||||||||||
Krishnan Viswanadhan, Pharm.D(13) | — | 9,960 | 9,960 | * | ||||||||||||
All directors and executive officers as a group (9 persons)(14) | 139,831 | 407,908 | 547,739 | 1.38 | % |
DEF 14A
CRGX
CARGO Therapeutics, Inc. Common Stock
24 Apr 24
Definitive proxy
4:27pm
Certain holders of more than 5% of our capital stock and their affiliated entities purchased shares of our common stock in the IPO, from the underwriters for payment in excess of $120,000 as summarized in the following table. The underwriters received the same underwriting discount from the sale of the shares of our common stock to these holders as they did from other shares of our common stock sold to the public in the IPO.
Name | Number of Shares of Common Stock | Aggregate Purchase Price ($) | ||||||
Samsara BioCapital, L.P.(1) | 666,666 | $ | 9,999,990 | |||||
Red Tree Venture Fund, L.P.(2) | 666,666 | $ | 9,999,990 | |||||
Entities affiliated with Perceptive(3) | 666,666 | $ | 9,999,990 | |||||
Third Rock Ventures V, L.P.(4) | 1,333,333 | $ | 19,999,995 | |||||
Nextech VII Oncology SCSP(5) | 800,000 | $ | 12,000,000 | |||||
Janus Henderson Biotech Innovation Master Fund Limited(6) | 1,333,333 | $ | 19,999,995 | |||||
Entities affiliated with RTW Funds(7) | 3,333,333 | $ | 49,999,995 |
- Prev
- 1
- Next